Potentially inappropriate prescribing detected by STOPP-START criteria: Are they really inappropriate?

Age and Ageing

Volumn 44, Issue 5, 2015, Pages 861-866

  Lozano Montoya, Isabel ^a   Vélez Diaz Pallarés, Manuel ^a   Delgado Silveira, Eva ^a   Montero Errasquin, Beatriz ^a   Cruz Jentoft, Alfonso Jose ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Older people; Potentially inappropriate prescribing; STOPP START

Indexed keywords

AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; FEMALE; GERIATRIC HOSPITAL; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; PHARMACIST ATTITUDE; POTENTIALLY INAPPROPRIATE PRESCRIBING; PRIORITY JOURNAL; SCREENING TOOL OF OLDER PERSON PRESCRIPTION AND SCREENING TOOL TO ALERT DOCTOR TO RIGHT TREATMENT CRITERIA; WALKING DIFFICULTY; CLINICAL PRACTICE; DISABILITY; DRUG INTERACTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GERIATRIC ASSESSMENT; GERIATRICS; MEDICATION THERAPY MANAGEMENT; ODDS RATIO; PATIENT CARE; PRACTICE GUIDELINE; PREVENTION AND CONTROL; RISK ASSESSMENT; RISK FACTOR; SPAIN; STANDARDS; UNIVERSITY HOSPITAL; VERY ELDERLY;

AGED, 80 AND OVER; DISABILITY EVALUATION; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GERIATRIC ASSESSMENT; GERIATRICS; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MEDICATION RECONCILIATION; ODDS RATIO; PATIENT CARE TEAM; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 84940643788     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afv079     Document Type: Article

References (30)

1. Spinewine A, Schmader KE, Barber N et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173-84.
2. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6-14.
3. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 2013; 38: 360-72.
4. Conejos MM, Sánchez Cuervo M, Delgado Silveira E et al. Potentially inappropriate drug prescription in older subjects across health care settings. Eur Geriatr Med 2010; 1: 9-14.
5. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013-9.
6. Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging 2012; 29: 829-37.
7. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-31.
8. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
9. Barry AR, Loewen PS, de Lemos J, Lee KG. Reasons for non-use of proven pharmacotherapeutic interventions: systematic review and framework development. J Eval Clin Pract 2012; 18: 49-55.
10. Denford S, Frost J, Dieppe P, Cooper C, Britten N. Individualisation of drug treatments for patients with longterm conditions: a review of concepts. BMJ Open 2014; 4: e004172.
11. Gallagher P, Lang PO, Cherubini A et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011; 67: 1175-88.
12. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-9.
13. Delgado-Silveira E, Alvarez-Diaz A, Perez-Menendez-Condea C, Muñoz-García M, Cruz-Jentoft A, Bermejo Vicedo T. Results of integrating pharmaceutical care in an Acute Geriatric Unit. Rev Esp Geriatr Gerontol 2012; 47: 49-54.
14. Onatade R, Auyeung V, Scutt G, Fernando J. Potentially inappropriate prescribing in patients on admission and discharge from an older peoples' unit of an acute UK hospital. Drugs Aging 2013; 30: 729-37.
15. O'Mahony D, Gallagher P, Ryan C et al. STOPP & START criteria: a new approach to detecting potentially prescribing in old age. Eur Geriatr Med 2010; 1: 45-51.
16. Lang PO, Hasso Y, Dramé M et al. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 2010; 39: 373-81.
17. Larsen MD, Rosholm JU, Hallas J. The influence of comprehensive geriatric assessment on drug therapy in elderly patients. Eur J Clin Pharmacol 2014; 70: 233-9.
18. Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 2012; 29: 495-510.
19. Viswanathan M, Kahwati LC, Golin CE et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med 2015; 175: 76-87.
20. O'Sullivan D, O'Mahony D, O'Connor MN et al. Impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging 2014; 31: 471-81.
21. Miller MD, Paradis CF, Houck PR et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-48.
22. Turner G, Clegg A. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing 2014; 43: 744-7.
23. Huerta C, Abbing-Karahagopian V, Requena G et al. Prevalence of use of benzodiazepines and related drugs in seven European databases: a cross-national descriptive study from the PROTECT-EU Project. In: 29 International Conference on Pharmacoepidemiology Therapeutic Risk Management, Montréal, Canada, 2013. https://boletinbifap. files.wordpress.com/2013/09/protect_bzd_descriptive.pdf (25 June 2014, date last accessed).
24. Maher AR, Maglione M, Bagley S et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for offlabel uses in adults: a systematic review and meta-analysis. JAMA 2011; 306: 1359-69.
25. Reid IR, Bolland MJ. Calcium risk-benefit updated-New WHI analyses. Maturitas 2014; 77: 1-3.
26. Mao PJ, Zhang C, Tang L et al. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 2013; 169: 106-11.
27. Reid IR. Should we prescribe calcium supplements for osteoporosis prevention? J Bone Metab 2014; 21: 21-8.
28. Kmietowicz Z. Vitamin D shows no clear evidence of benefits despite hundreds of studies. BMJ 2014; 348: g2489.
29. Stone NJ, Intwala S, Katz D. Statins in very elderly adults (debate). J Am Geriatr Soc 2014; 62: 943-5.
30. Berthold HK, Gouni-Berthold I. Lipid-lowering drug therapy in elderly patients. Curr Pharm Des 2011; 17: 877-93.